[Antiarrhythmic effect of oxylidine].
D031841:Aconitum / Q000037:antagonists & inhibitors*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000517:prevention & control*; D001775:Blood Circulation / Q000187:drug effects; D002122:Calcium Chloride / Q000037:antagonists & inhibitors*; D002415:Cats; D003864:Depression, Chemical; D004558:Electric Stimulation; D005730:Ganglionic Blockers / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D006325:Heart Atria / Q000187:drug effects*; D066298:In Vitro Techniques; D007273:Injections, Intramuscular; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D008297:Male; D011342:Procainamide / Q000627:therapeutic use*; D011812:Quinuclidines / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats
D000889:Anti-Arrhythmia Agents; D005730:Ganglionic Blockers; D011812:Quinuclidines; D011342:Procainamide; D002122:Calcium Chloride
Antiaritmicheskaia aktivnost' oksilidina.